I agree that this site is using cookies. You can find further informations here.
X
Crowe, Brenda
77  results:
Search for persons X
?
1

Baricitinib for systemic lupus erythematosus: a double-blin..:

Morand, Eric F ; Vital, Edward M ; Petri, Michelle...
The Lancet.  401 (2023)  10381 - p. 1001-1010 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Interdisciplinary Safety Evaluation for Learning and Decisi..:

Ball, Greg ; Hendrickson, Barbara A. ; Freedman, Amy L....
Therapeutic Innovation & Regulatory Science.  , 2021
Link: https://doi.org/10.1007/..
 
?
3

Clinical Trial Drug Safety Assessment for Studies and Submi..:

Nilsson, Mary ; Crowe, Brenda ; Anglin, Greg...
Statistics in Biopharmaceutical Research.  12 (2020)  4 - p. 498-505 , 2020
Link: https://doi.org/10.1080/..
 
?
4

Baricitinib-associated changes in global gene expression du..:

Dörner, Thomas ; Tanaka, Yoshiya ; Petri, Michelle A...
Lupus Science & Medicine.  7 (2020)  1 - p. e000424 , 2020
Link: https://doi.org/10.1136/..
 
?
5

Clinical Trial Drug Safety Assessment With Interactive Visu..:

Wang, Wei ; Revis, Rebeka ; Nilsson, Mary.
Statistics in Biopharmaceutical Research.  13 (2020)  3 - p. 355-366 , 2020
Link: https://doi.org/10.1080/..
 
?
6

Adaptation of the robust method to large distributions of r..:

Beasley Jr., Charles M. ; Crowe, Brenda ; Nilsson, Mary...
Journal of Biopharmaceutical Statistics.  29 (2019)  3 - p. 516-528 , 2019
Link: https://doi.org/10.1080/..
 
?
7

Reference Limits for Outlier Analyses in Randomized Clinica..:

Beasley, Charles M. ; Crowe, Brenda ; Nilsson, Mary...
Therapeutic Innovation & Regulatory Science.  51 (2017)  6 - p. 683-737 , 2017
Link: https://doi.org/10.1177/..
 
?
8

[P1–044]: SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIV..:

Carlson, Christopher D. ; Anglin, Greg ; Case, Michael G....
Alzheimer's & Dementia.  13 (2017)  7S_Part_5 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
9

Reporting Adverse Drug Reactions in Product Labels:

Crowe, Brenda ; Chuang-Stein, Christy ; Lettis, Sally.
Therapeutic Innovation & Regulatory Science.  50 (2016)  4 - p. 455-463 , 2016
Link: https://doi.org/10.1177/..
 
?
10

The FDA's Final Rule on Expedited Safety Reporting: Statist..:

Wittes, Janet ; Crowe, Brenda ; Chuang-Stein, Christy...
Statistics in Biopharmaceutical Research.  7 (2015)  3 - p. 174-190 , 2015
Link: https://doi.org/10.1080/..
 
?
11

Seeing is believing: good graphic design principles for med..:

Duke, Susan P. ; Bancken, Fabrice ; Crowe, Brenda...
Statistics in Medicine.  34 (2015)  22 - p. 3040-3059 , 2015
Link: https://doi.org/10.1002/..
 
?
12

Protocol for a mixed-methods study of supplemental oxygen i..:

Belkin, Amanda ; Fier, Kaitlin ; Albright, Karen...
BMC Pulmonary Medicine.  14 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
13

Current Practices, Challenges, and Statistical Issues With ..:

Crowe, Brenda ; Brueckner, Andreas ; Beasley, Charles.
Statistics in Biopharmaceutical Research.  5 (2013)  3 - p. 180-193 , 2013
Link: https://doi.org/10.1080/..
 
?
14

Comparison of Bayesian and Frequentist Meta-Analytical Appr..:

Bennett, Monica M. ; Crowe, Brenda J. ; Price, Karen L...
Journal of Biopharmaceutical Statistics.  23 (2013)  1 - p. 129-145 , 2013
Link: https://doi.org/10.1080/..
 
?
15

Prospective Safety Surveillance of GH-Deficient Adults: Com..:

Hartman, Mark L. ; Xu, Rong ; Crowe, Brenda J....
The Journal of Clinical Endocrinology & Metabolism.  98 (2013)  3 - p. 980-988 , 2013
Link: https://doi.org/10.1210/..
 
1-15